The purpose of this post-market clinical follow up study is to assess the safety and effectiveness of the SYMBOL range of medical devices. The study will evaluate the outcome of Total Hip Arthroplasty using medical devices from SYMBOL range over a period of 10 years.
Patient age > 18 years at implantation.
Patient who will undergo, during the study's period of inclusion, a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device (DEDIENNE Santé).
Patient informed of his/her participation and willing to participate in the study.
Patient able to read, write and understand French.
Patient deprived of freedom, under guardianship/curatorship or placed under judicial protection
Patient unable to follow study procedures.
Patient who has already been included in the study for a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device.
Dedienne Sante S.A.S.
Lead sponsor
EVAMED
Collaborator